Skip to main content
. 2019 Apr 3;19:302. doi: 10.1186/s12885-019-5475-x

Fig. 1.

Fig. 1

Kaplan-Meier survival analysis of colorectal cancer patients stratified by SLC2A3 expression levels (Discovery set). Overall survival (a) and disease-free survival (b) curve of patients in discovery set with high versus low SLC2A3 expression levels. P-values for significance of difference between high and low expression were calculated using the log-rank test